Dated disclosed rounds · latest 2024-07-30
Series B
Flo Health
Femtech — period & fertility tracking app; Women's health, fertility & cycle-tracking app
VerifiedSeries BLondon
- Companies House
- 12898410
- GLEIF LEI
- Not matched
- Latest evidence
- 2024-07-30
- Evidence snapshot
- 2026-09-03
Exact award notices · latest No exact award match
2026-07-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
4 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Series B
$200M (2024, unicorn/growth round); $50M (Series B, Sept 2021) · 3 named investors
FundingSource fact Series C
$200M+ (~€182M) · 1 named investor
RegistryRegistry fact Company incorporated
FLO HEALTH UK LIMITED · company 12898410
Latest disclosed round
Growth round (stage label ambiguous in sources; confirmed Series B in 2021)
- Date
- 2024-07-30
- Amount
- USD 200m
- Sector
- Consumer / marketplace; Healthtech & digital health
- Companies House
- 12898410
- ONS region
- London
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
3 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| General Atlantic | lead | 2024-07-30 | TechCrunch ↗ · Generalatlantic ↗ · Health ↗ | reviewed canonical company and investor alias resolutiondocumented · published |
| Target Global | participant | 2024-07-30 | TechCrunch ↗ · Health ↗ · Health ↗ | reviewed canonical company and investor alias resolutiondocumented · published |
| VNV Global | participant | 2024-07-30 | TechCrunch ↗ · Health ↗ · Health ↗ | reviewed canonical company and investor alias resolutiondocumented · published |
Funding record
2 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2024-07-30 | Series B | $200M (2024, unicorn/growth round); $50M (Series B, Sept 2021) | 3 additional source-listed names | TechCrunch ↗ · Health ↗ · Health ↗ |
| 2024-07-01 | Series C | $200M+ (~€182M) | General Atlantic | TechCrunch ↗ · Generalatlantic ↗ |
Companies House status and filing snapshot
FLO HEALTH UK LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2020-09-23
- Dissolved
- Not applicable
- Company number
- 12898410
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2025-12-31
- Next accounts due
- 2027-09-30
- Confirmation made up to
- 2025-10-07
- Registry snapshot
- 2026-07-01
- Live check
- Bulk snapshot only
82990Other business support service activities n.e.c.
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.